| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 1.88e-07 | 20 | 12 | 3 | GO:0004653 | |
| GeneOntologyMolecularFunction | acetylgalactosaminyltransferase activity | 1.07e-06 | 35 | 12 | 3 | GO:0008376 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 1.92e-05 | 288 | 12 | 4 | GO:0016757 | |
| GeneOntologyMolecularFunction | carbohydrate binding | 2.56e-05 | 310 | 12 | 4 | GO:0030246 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 9.22e-05 | 153 | 12 | 3 | GO:0008194 | |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 2.39e-04 | 211 | 12 | 3 | GO:0016758 | |
| GeneOntologyBiologicalProcess | macromolecule glycosylation | 6.71e-06 | 252 | 11 | 4 | GO:0043413 | |
| GeneOntologyBiologicalProcess | protein glycosylation | 6.71e-06 | 252 | 11 | 4 | GO:0006486 | |
| GeneOntologyBiologicalProcess | glycosylation | 8.82e-06 | 270 | 11 | 4 | GO:0070085 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation via threonine | 1.16e-05 | 10 | 11 | 2 | GO:0018243 | |
| GeneOntologyBiologicalProcess | protein O-linked glycosylation | 2.05e-05 | 105 | 11 | 3 | GO:0006493 | |
| GeneOntologyBiologicalProcess | glycoprotein biosynthetic process | 2.65e-05 | 357 | 11 | 4 | GO:0009101 | |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 5.47e-05 | 430 | 11 | 4 | GO:0009100 | |
| GeneOntologyBiologicalProcess | O-glycan processing | 2.31e-04 | 43 | 11 | 2 | GO:0016266 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | 2.51e-04 | 1226 | 11 | 5 | GO:1901135 | |
| GeneOntologyBiologicalProcess | carbohydrate derivative biosynthetic process | 4.34e-04 | 736 | 11 | 4 | GO:1901137 | |
| GeneOntologyBiologicalProcess | peptidyl-threonine modification | 1.93e-03 | 125 | 11 | 2 | GO:0018210 | |
| GeneOntologyCellularComponent | Golgi membrane | 5.57e-04 | 721 | 12 | 4 | GO:0000139 | |
| GeneOntologyCellularComponent | cullin-RING ubiquitin ligase complex | 6.32e-03 | 212 | 12 | 2 | GO:0031461 | |
| Domain | RICIN | 1.98e-09 | 28 | 12 | 4 | SM00458 | |
| Domain | RICIN_B_LECTIN | 1.98e-09 | 28 | 12 | 4 | PS50231 | |
| Domain | Ricin_B_lectin | 2.65e-09 | 30 | 12 | 4 | IPR000772 | |
| Domain | Ricin_B_lectin | 4.62e-07 | 25 | 12 | 3 | PF00652 | |
| Domain | Glyco_trans_2-like | 8.15e-07 | 30 | 12 | 3 | IPR001173 | |
| Domain | Glycos_transf_2 | 8.15e-07 | 30 | 12 | 3 | PF00535 | |
| Domain | - | 1.68e-05 | 81 | 12 | 3 | 3.90.550.10 | |
| Domain | Nucleotide-diphossugar_trans | 2.16e-05 | 88 | 12 | 3 | IPR029044 | |
| Domain | - | 8.29e-03 | 218 | 12 | 2 | 1.10.10.10 | |
| Domain | WHTH_DNA-bd_dom | 1.01e-02 | 242 | 12 | 2 | IPR011991 | |
| Pathway | KEGG_O_GLYCAN_BIOSYNTHESIS | 1.89e-06 | 30 | 12 | 3 | M6929 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.57e-05 | 60 | 12 | 3 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.73e-05 | 62 | 12 | 3 | M546 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.40e-05 | 109 | 12 | 3 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 9.93e-05 | 111 | 12 | 3 | M27416 | |
| Pubmed | 1.09e-06 | 5 | 12 | 2 | 22186971 | ||
| Pubmed | A Cellular Mechanism to Detect and Alleviate Reductive Stress. | 3.92e-06 | 9 | 12 | 2 | 32941802 | |
| Pubmed | Genome-wide association study of intelligence: additive effects of novel brain expressed genes. | 2.28e-05 | 21 | 12 | 2 | 22449649 | |
| Pubmed | 2.51e-05 | 22 | 12 | 2 | 25107907 | ||
| Pubmed | 3.00e-05 | 24 | 12 | 2 | 31740596 | ||
| Pubmed | 3.00e-05 | 24 | 12 | 2 | 31882545 | ||
| Pubmed | 4.72e-05 | 30 | 12 | 2 | 12676797 | ||
| Pubmed | Galnt1 is required for normal heart valve development and cardiac function. | 6.83e-05 | 36 | 12 | 2 | 25615642 | |
| Pubmed | 8.45e-05 | 40 | 12 | 2 | 22643896 | ||
| Pubmed | A global genomic transcriptional code associated with CNS-expressed genes. | 1.57e-04 | 318 | 12 | 3 | 16919269 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 9.68e-08 | 20 | 9 | 3 | 433 | |
| Coexpression | NRL_DN.V1_UP | 2.97e-05 | 137 | 12 | 3 | M2798 | |
| Coexpression | CRX_NRL_DN.V1_UP | 3.17e-05 | 140 | 12 | 3 | M2796 | |
| Coexpression | WAGNER_APO2_SENSITIVITY | 6.21e-05 | 26 | 12 | 2 | M13240 | |
| Coexpression | GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN | 9.02e-05 | 199 | 12 | 3 | M8211 | |
| Coexpression | GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP | 9.15e-05 | 200 | 12 | 3 | M6558 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.33e-05 | 179 | 12 | 3 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.51e-05 | 187 | 12 | 3 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.61e-05 | 191 | 12 | 3 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 1.69e-05 | 194 | 12 | 3 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.71e-05 | 195 | 12 | 3 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 5.04e-04 | 126 | 12 | 2 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-9|TCGA-Kidney / Sample_Type by Project: Shred V9 | 5.53e-04 | 132 | 12 | 2 | f1ef63a4842ab6ca584a9dcc2dd5b2108fc990aa | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Sema3e_Kank4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.78e-04 | 135 | 12 | 2 | 54b2aaf8d322e01a3ff6099c2422d68ecccf96b4 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.87e-04 | 136 | 12 | 2 | 88b5c839d0446c6d6b7e81fc4d48f5e7e96eea11 | |
| ToppCell | PBMC-Control-Hematopoietic-Platelet-Platelet-plt_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.87e-04 | 136 | 12 | 2 | 27a41463e6f16deb5b1d4f17fefded9959038c07 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.13e-04 | 139 | 12 | 2 | d441c29852c28928ecb696b4b95e31b30c17116b | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue-3|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.51e-04 | 154 | 12 | 2 | 4e9203c220a44c70cd7979796a0b461991422257 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Lymphocytic-T_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-04 | 156 | 12 | 2 | 0bd32876413f3308f838f266e8c39ea0937ce5b9 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.90e-04 | 158 | 12 | 2 | 55214d674808584e4d48f8c5e3b8c0e206cb9bb8 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.90e-04 | 158 | 12 | 2 | 8e48952af0831a1fc71ad422e8216b5a92a75991 | |
| ToppCell | TCGA-Thryoid-Solid_Tissue_Normal-Thryoid_normal_tissue|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 7.90e-04 | 158 | 12 | 2 | e5b55c15a8c99c8d7fc94949f0d3c22e0c3fee7b | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-04 | 159 | 12 | 2 | c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-04 | 159 | 12 | 2 | 9f6607e395bcca9cb1c83199bdbbaaa62a93938d | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.20e-04 | 161 | 12 | 2 | c61283c301a87bb802f6f8ce79c26067032dd7d9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 8.20e-04 | 161 | 12 | 2 | 9864d8b0929dacf4be7a4e97d2527ac3120ea264 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-04 | 162 | 12 | 2 | 6972d45f4bd4b6522bf93295f7e9dca7c6cba1f3 | |
| ToppCell | mild-Myeloid-Eosinophils|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.41e-04 | 163 | 12 | 2 | 7c57d541a88e9afa079e95b8a6ecdea60a0c6aaa | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F-|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-04 | 166 | 12 | 2 | 1cc291a04f4144abba4aca7badeb7776db05d903 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-F|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.72e-04 | 166 | 12 | 2 | 2887f4f0c218cbcbcc82eef27aa4ee714b35cddb | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.93e-04 | 168 | 12 | 2 | 35ce3b2b9c9997d4c101da5949c7271d6a6b8f12 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.93e-04 | 168 | 12 | 2 | 53a982869dbf14f6a948589be9f2f3df3b9a7e97 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-04 | 169 | 12 | 2 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-04 | 169 | 12 | 2 | 0cece9b2bb1f58e465c20ec8735a4fc3c1021f03 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.03e-04 | 169 | 12 | 2 | d161dd8eb22633392b6c6466ee9eff4042464149 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.03e-04 | 169 | 12 | 2 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.03e-04 | 169 | 12 | 2 | 6937c46b119d4ce382fc8c2fa5925ede5ae89c81 | |
| ToppCell | Ionocyte|World / Class top | 9.14e-04 | 170 | 12 | 2 | d2e592f2a679e6a8d32f2b752d9a3c493e50ced4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial-N_cells_(NTS+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.14e-04 | 170 | 12 | 2 | 02f0be0aab8ba2d35a83238609352ef3677511c9 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.14e-04 | 170 | 12 | 2 | 513d9036aa41d4d902da8baa66a66206abb6f3b0 | |
| ToppCell | mild-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 9.24e-04 | 171 | 12 | 2 | 5c8198182495bda7a826e9d80aa467f4eb1094ec | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-04 | 171 | 12 | 2 | 05fcc72df50a380a913821b5781d9621df37d328 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.24e-04 | 171 | 12 | 2 | 48fc4eca18b102b5ec5050f758281292ee8e10c6 | |
| ToppCell | Ionocyte-iono-2|World / Class top | 9.46e-04 | 173 | 12 | 2 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-5_VIP_KCNJ2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.57e-04 | 174 | 12 | 2 | 8d8cf8ad17dcc364f867e36b10834a21c0e36ad2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.68e-04 | 175 | 12 | 2 | 5a9160a9d05e01d945e77fd81bb0bd87139545cd | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.79e-04 | 176 | 12 | 2 | 07abf29d681abdd6c7cc87f9eaf9377e92ce212c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 9.79e-04 | 176 | 12 | 2 | 052b54c4337ca728974a106b6dbd3b72dd28eb23 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-neuro-epithelial|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.79e-04 | 176 | 12 | 2 | 2e1003dc373b14d27f0464d980453fdcfc1005f0 | |
| ToppCell | pdx-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 9.79e-04 | 176 | 12 | 2 | 1e21f80cf0e695ffdd63e4a72cf1e3fa41b60341 | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.00e-03 | 178 | 12 | 2 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.00e-03 | 178 | 12 | 2 | 3c973aac16988e88f5677d3d695dd772ccfd6570 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.02e-03 | 180 | 12 | 2 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L3_VIP_CBLN1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 181 | 12 | 2 | 7846c7b33d1b89364c5a704edaa86520db731c89 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 181 | 12 | 2 | 154d5e586cab25155c6d06dfe6ae01203b88e0fb | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.03e-03 | 181 | 12 | 2 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-5_VIP_TOX2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 181 | 12 | 2 | 35bcdcd2651149692e5b150e887c0f450c81d2d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-4_VIP_DSEL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-03 | 181 | 12 | 2 | 70eff83dd85691e977972c660731394d2fcf5cdf | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|CF / Disease state, Lineage and Cell class | 1.05e-03 | 182 | 12 | 2 | a8dfc59a3974e3433f434676b7c2749d0fcfc8b2 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.06e-03 | 183 | 12 | 2 | 514b72a1ae55656934839800513385e19bc240e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-03 | 183 | 12 | 2 | 85446581999cd66b171c4f69b7eb8b0bbbaa8617 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-03 | 183 | 12 | 2 | f55081068213cc1cdb2acad58ff10f6b48b44c72 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-03 | 184 | 12 | 2 | 30fddbc9696476d4d7f08e53f84ea994a4ed873a | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-03 | 184 | 12 | 2 | 96926efa220f03d0787322c9519bb9e8f64f74d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.07e-03 | 184 | 12 | 2 | 32473dbdb2de66391157c5814ef34e790806e4f2 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-03 | 184 | 12 | 2 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-03 | 184 | 12 | 2 | 49eccf72725593a8fb4a529e7985a5c413b3ca6a | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-03 | 184 | 12 | 2 | 41164109d9d7bb1c431220e2e85e08dc5f56856d | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.08e-03 | 185 | 12 | 2 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.10e-03 | 187 | 12 | 2 | f31d865ce2a21bdf64dbe29ee3e4505ab482604a | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-03 | 187 | 12 | 2 | c667fae6440dc98072b584f203d00f0fb1cb2f21 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-03 | 188 | 12 | 2 | 6ee3f8f94ea7bdf652c9575fc65bff08070093a4 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | 7471c194276161422326647f09022e94f3d1640c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | a244fcd092d5bd544e503366b1439b0fbc1ee00e | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.12e-03 | 188 | 12 | 2 | ecc2364d946f97ae0212fd6739960c9fc75e4919 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-03 | 188 | 12 | 2 | c66fccdfe68760b8c3efca77e3c25966dc9a8a5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | c8530c9ff98666c64a94683261af4288cb790a7e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-03 | 188 | 12 | 2 | 053c251d3ddbeb866f34565aefca4535517b4387 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-03 | 189 | 12 | 2 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-03 | 189 | 12 | 2 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-03 | 189 | 12 | 2 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-03 | 189 | 12 | 2 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 1.13e-03 | 189 | 12 | 2 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.14e-03 | 190 | 12 | 2 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-03 | 190 | 12 | 2 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-03 | 190 | 12 | 2 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-03 | 190 | 12 | 2 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 190 | 12 | 2 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-03 | 190 | 12 | 2 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-03 | 190 | 12 | 2 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-03 | 190 | 12 | 2 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 191 | 12 | 2 | ece87127f85939e61b1048d968ed96f0e87c3a79 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-03 | 191 | 12 | 2 | 764c3a8829ae1253a0790744138266e81fc075ec | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.15e-03 | 191 | 12 | 2 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-03 | 191 | 12 | 2 | de54dab85db70f847de75b3b6d7667a0e13b9bfb | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibro-meso-mesothelial_cell-Mesothelium-Mesothelium_L.2.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.15e-03 | 191 | 12 | 2 | b7713aba839e7a1f548b7b9d8893067bcc6d7ee7 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.15e-03 | 191 | 12 | 2 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-03 | 191 | 12 | 2 | 478e8341ee03b05501e2233e02cef5f97492c95d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-03 | 191 | 12 | 2 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.16e-03 | 192 | 12 | 2 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-03 | 192 | 12 | 2 | f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-03 | 192 | 12 | 2 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-03 | 192 | 12 | 2 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| Drug | Levopropoxyphene napsylate [5714-90-9]; Up 200; 7.4uM; HL60; HT_HG-U133A | 2.60e-06 | 198 | 12 | 4 | 2980_UP | |
| Drug | uniconazole | 1.40e-05 | 11 | 12 | 2 | CID006436604 | |
| Drug | K ha | 1.98e-05 | 13 | 12 | 2 | CID000448962 | |
| Drug | isovanillin | 3.88e-05 | 18 | 12 | 2 | CID000012127 | |
| Drug | AC1L1KJQ | 6.98e-05 | 24 | 12 | 2 | CID000005529 | |
| Drug | CGP74514A | 9.55e-05 | 28 | 12 | 2 | CID002794188 | |
| Drug | protocatechuic aldehyde | 9.55e-05 | 28 | 12 | 2 | CID000008768 | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 1.27e-04 | 194 | 12 | 3 | 6995_DN | |
| Drug | Dimethisoquin hydrochloride [2773-92-4]; Down 200; 13uM; HL60; HT_HG-U133A | 1.29e-04 | 195 | 12 | 3 | 2151_DN | |
| Drug | Betulin [473-98-3]; Up 200; 9uM; HL60; HT_HG-U133A | 1.33e-04 | 197 | 12 | 3 | 2952_UP | |
| Drug | mellein | 1.33e-04 | 33 | 12 | 2 | CID000028516 | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 1.35e-04 | 198 | 12 | 3 | 4142_UP | |
| Drug | Carisoprodol [78-44-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 1.37e-04 | 199 | 12 | 3 | 1314_UP | |
| Drug | UDP-N-acetylglucosamine | 1.45e-04 | 203 | 12 | 3 | CID000001167 | |
| Drug | vanillin | 1.96e-04 | 40 | 12 | 2 | CID000001183 | |
| Drug | linopirdine | 2.27e-04 | 43 | 12 | 2 | CID000003932 | |
| Drug | AC1L1UI8 | 2.60e-04 | 46 | 12 | 2 | CID000010107 | |
| Drug | butyraldehyde | 2.83e-04 | 48 | 12 | 2 | CID000000261 | |
| Drug | sialyllactose | 3.46e-04 | 53 | 12 | 2 | CID000123914 | |
| Drug | TiO2 | 5.52e-04 | 67 | 12 | 2 | CID000026042 | |
| Drug | mazindol | 7.10e-04 | 76 | 12 | 2 | CID000004020 | |
| Drug | Glc-ceramide | 1.37e-03 | 106 | 12 | 2 | CID005319015 | |
| Drug | cytokinin | 1.48e-03 | 110 | 12 | 2 | CID000003830 | |
| Disease | Crohn's disease | 6.60e-04 | 441 | 12 | 3 | EFO_0000384 | |
| Disease | amino acid measurement | 2.28e-03 | 678 | 12 | 3 | EFO_0005134 | |
| Disease | colorectal health | 2.91e-03 | 201 | 12 | 2 | EFO_0008460 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 3.73e-03 | 228 | 12 | 2 | EFO_0003948, MONDO_0004975 | |
| Disease | executive function measurement | 9.82e-03 | 376 | 12 | 2 | EFO_0009332 | |
| Disease | bilirubin measurement | 1.34e-02 | 442 | 12 | 2 | EFO_0004570 | |
| Disease | inflammatory bowel disease | 1.38e-02 | 449 | 12 | 2 | EFO_0003767 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YFRGYESDMNWEKGE | 1141 | Q06278 | |
| GVFWMEYGDFVRYFD | 771 | O75808 | |
| MWDFDIYGDLYFEKA | 181 | O75140 | |
| GDAMRGAFDWEMYYK | 281 | Q86SR1 | |
| LFDRKGYMFDYEYDW | 311 | Q9Y6M4 | |
| GYMFDYEYDWIGKQL | 316 | Q9Y6M4 | |
| YFEEIGTYDAGMDIW | 301 | Q8IUC8 | |
| WEEYSKGADYMDCLY | 91 | Q13617 | |
| GDAMRGAFDWEMYYK | 276 | Q49A17 | |
| MGKSMWYDGEFLYSF | 101 | Q92185 | |
| KWYFEDCGKEGYGFV | 1081 | Q13018 | |
| DRGYMDKDGYFWFVA | 461 | Q53FZ2 | |
| GYDYDVKFWDFAGMD | 201 | Q9NW82 |